Primary Record
TOZADENANT
Note: Only for scientific research or as raw materials for production.
- In stock
- 6,099 g
- Purity
- 99.5 %
- CAS
- 870070-55-6
Compound Identifiers & Properties
- CAS
- 870070-55-6
- PubChem CID
- 11618368
- SMILES
- CC1(CCN(CC1)C(=O)NC2=NC3=C(C=CC(=C3S2)N4CCOCC4)OC)O
- Canonical SMILES
- COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12
Names & Synonyms
- TOZADENANT
- 870070-55-6
- SYN-115
- tozadenantum
- Tozadenant [USAN]
- Tozadenant (USAN)
- SYN115
- Tozadenant [USAN:INN]
- TOZADENANT [INN]
- RefChem:190521
- D03OQI
- Ro-2
- UNII-D9K857J81I
- D9K857J81I
- TOZADENANT [WHO-DD]
- RO-4494351
- C19H26N4O4S
- cc-340
- A2A (3)
- MFCD21642026
- GTPL5611
- orb1299923
- SCHEMBL1628246
- 4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide
- CHEMBL2105747
- SCHEMBL29361846
- A2A-(3)
- CTK8C0579
- RO4494351
- CHEBI:177494
- XNBRWUQWSKXMPW-UHFFFAOYSA-N
- A-2A (3)
- GLXC-90401
- Ro-4494351000
- Ro-4494351-002
- BCP06963
- 3711AC
- ANW-64921
- BDBM50011294
- EX-A11088
- ZINC13986943
- RO4494351-000
- RO4494351-002
- AKOS016005201
- Ro-4494351-000
- 4-HYDROXY-N-[4-METHOXY-7-(4-MORPHOLINYL)-2-BENZOTHIAZOLYL]-4-METHYL-1-PIPERIDINECARBOXAMIDE
- CS-0359
- DB12203
- PB19761
- RL05395
- CID11618368
- KS-000006M4
- NCGC00378653-02
- AJ-64560
- AK103300
- AS-34303
- HY-10995
- AB0165784
- DB-332345
- TC-153666
- A3885
- NS00071044
- J3.144.088B
- A11560
- C-8875
- D10174
- A862938
- 1-Piperidinecarboxamide, 4-hydroxy-N-(4-methoxy-7-(4-morpholinyl)-2-benzothiazolyl)-4-methyl-
- 4-hydroxy-N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-methylpiperidine-1-carboxamide
- 4-Hydroxy-N-(4-methoxy-7-morpholinobenzo(d)thiazol-2-yl)-4-methylpiperidine-1-carboxamide
- 4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-2-benzo-thiazolyl]-4-methyl-1-piperidinecarboxamide
- BRD-K93045741-001-01-0
- Q27089009
- 4-Methoxy-7-morpholino-2-[(4-hydroxy-4-methylpiperidino)carbonylamino]benzothiazole
- A2a receptor antagonists (Parkinson's disease), Synosia/Roche
- 4-Hydroxy-N-(4-methoxy-7-morpholino-1,3-benzothiazol-2-yl)-4-methyl-piperidine-1-carboxamide
- ~{N}-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-methyl-4-oxidanyl-piperidine-1-carboxamide
- Adenosine A2a receptor antagonists (Parkinson's disease), Synosia/Roche
- 4-hydroxy-n-(4-methoxy-7-(4-morpholinyl)-2-benzothiazolyl)-4-methyl-1-piperidinecarboxamide
- N-[4-Methoxy-7-morpholinobenzothiazole-2-yl]-4-hydroxy-4-methylpiperidine-1-carboxamide
- RO-4494351; RO4494351; RO 4494351;SYN115; SYN 115; Tozadenant
- 4-hydroxy-4-methyl-piperidine-1-carboxylic acid(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
- 4-hydroxy-N-(4-methoxy-7-(morpholin-4-yl)-1,3-benzothiazol-2-yl)-4-methylpiperidine-1-carboxamide
- 4-hydroxy-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-4-methyl-piperidine-1-carboxamide
- 4-HYDROXY-N-[4-METHOXY-7-(MORPHOLIN-4-YL)-1,3-BENZOTHIAZOL-2-YL]-4-METHYLPIPERIDINE-1-CARBOXAMIDE
- 9XW
- A2A